| Intercept | Slope | χ2(3 df) * | P * | AIC ** |
---|
Uniform effect (absolute scale) | 27.7 | – | | | 1638.3 |
Intercept and slope | 7.9 | −0.69 | 82.3 | 10−17 | |
Slope (relative scale) | – | −0.90 | 13.9 | 0.003 | 1576.8 |
- The intercept and the slope were calculated with a linear mixed-effects model using the type of β2-agonist and study as grouping variables. The intercept alone indicates that β2-agonists decrease the post-exercise FEV1 decline by an absolute effect of 27.7 pp. (95% CI: 22.1 to 33.4 pp). The slope alone indicates that β2-agonists decrease the post-exercise FEV1 decline by a relative effect of 90% (95% CI: 72% to 109%). Abbreviations: pp., percentage points
- * Anova test comparing the model on the row with the model on the row above
- ** AIC, Akaike information criterion. AIC estimates the relative quality of statistical models, lower AIC value is preferable